Enzyme Engineering & Optimization Services
Enzyme Stability and Formulation Optimization
Develop liquid and solid enzyme dosage forms that hold catalytic activity through storage, handling, and use.
What Formulation Optimization Solves
Enzymes are efficient biological catalysts, but their activity is only as durable as the formulation that carries them. Loss of activity during storage or under physiological conditions limits where an enzyme can be used, whether the intended application is a therapeutic product, an ex vivo processing step, or a diagnostic reagent. Formulation optimization addresses that gap by defining a dosage form and excipient environment in which the enzyme retains its structure and function.
Our service develops liquid or solid enzyme formulations and characterizes them with complementary analytical methods. The work combines buffer and pH optimization, stabilizer and excipient selection, control of environmental factors such as temperature, interfaces, light, and agitation, and stability testing that tracks activity alongside physical degradation. Where a dry form is preferred, lyophilization and drying support are included, and delivery system development can be scoped when the application requires it.
Slowing Chemical Degradation
Enzyme activity can decline through chemical routes that are sensitive to pH, buffer species, and the surrounding excipient environment. Formulation work maps those dependencies and selects conditions that slow degradation.
- Buffer species and pH screening
- Excipient compatibility assessment
- Activity monitoring across candidate conditions
Controlling Aggregation and Fragmentation
Physical instability such as aggregation or fragmentation can reduce the amount of functional enzyme and complicate downstream use. Analytical testing is used to detect these changes early in formulation development.
- Aggregation and fragmentation analysis
- Structural characterization of primary, secondary, and tertiary structure
- Solubility and physical form assessment
Liquid, Powder, and Delivery Options
The right physical form depends on the application and the storage and handling conditions the product must survive. Liquid, powder, granulate, and microgranulate formats can be evaluated, with drying support where a solid form is preferred.
- Liquid and solid form evaluation
- Lyophilization and drying support
- Delivery system development when scoped
Formulation Parameters We Optimize
Formulation development is organized around the parameters that most directly influence enzyme activity and physical integrity. Each parameter is evaluated against the intended storage and use conditions, and the resulting data set supports selection of a lead formulation rather than a single fixed recipe.
The table below summarizes the parameter families commonly addressed in an enzyme formulation project. The specific scope, number of candidates, and analytical depth are defined case by case in the project statement of work.
| Parameter | What Is Evaluated | Typical Analytical Readout | Scope Basis |
|---|---|---|---|
| Buffer and pH | Buffer species and pH range matched to the enzyme's stability profile | Activity assay across pH and buffer conditions | Candidate conditions scoped per project |
| Stabilizers and excipients | Sugars, polyols, amino acids, surfactants, and other stabilizer classes | Activity retention and physical stability readouts | Excipient panel scoped per project |
| Lyophilization and drying | Freeze-drying or drying support for solid dosage forms | Activity recovery after reconstitution | Cycle support scoped per project |
| Aggregation and fragmentation | Physical instability under stress and storage conditions | Aggregation and fragmentation analysis | Stress conditions scoped per project |
| Structural integrity | Primary, secondary, and tertiary structure of the formulated enzyme | Structural characterization methods | Method panel scoped per project |
| Compatibility | Excipient and container/closure contact compatibility | Compatibility testing with excipients and containers | Contact materials scoped per project |
| Storage conditions | Temperature, light, and handling conditions relevant to the product | Real-time and accelerated stability testing | Condition set scoped per project |
| Physical form and solubility | Liquid, powder, granulate, or microgranulate formats | Solubility and physical form assessment | Format options scoped per project |
How a Formulation Project Runs
Engagement follows a defined sequence from project definition through stability testing and reporting. Steps are described below; the depth of each step is agreed in the statement of work.
Define the Target Product Profile
We start from the intended application, the enzyme's known liabilities, and the storage and handling conditions the product must survive, then translate these into formulation requirements.
Screen Buffer and pH Conditions
Buffer species and pH are evaluated against enzyme activity and chemical stability, narrowing the condition space before stabilizer screening begins.
Select Stabilizers and Excipients
Candidate stabilizers and excipients are screened for their effect on activity retention and physical stability, with compatibility against excipients and container materials assessed.
Develop the Dosage Form
Liquid or solid formats are developed, including lyophilization or drying support where a dry form is preferred, and delivery system development when the application requires it.
Analytical and Development Capabilities
Formulation decisions are only as good as the data behind them. Our service pairs formulation development with the analytical methods needed to detect activity loss and physical degradation, so that candidate selection is based on measured behavior rather than assumption.
Analytical coverage spans enzyme activity, aggregation and fragmentation, and structural characterization, and can be extended to compatibility and solubility assessments depending on the project.
Enzyme Activity Assays
Activity assays are the primary readout for formulation performance, used to compare candidate conditions and to track retention through storage and stress testing.
- Activity comparison across candidate formulations
- Retention tracking during stability studies
- Readouts aligned to the intended application
Aggregation and Fragmentation Analysis
Physical instability can reduce functional enzyme even when chemical degradation is controlled. Aggregation and fragmentation analysis is used to detect these changes and to compare formulation candidates.
- Aggregation analysis across stress conditions
- Fragmentation assessment
- Comparison of candidate formulations
Structural Characterization
Structural methods provide information on primary, secondary, and tertiary structure, supporting assessment of whether formulation conditions preserve the enzyme's folded state.
- Primary, secondary, and tertiary structure assessment
- Comparison before and after stress or drying
- Support for formulation selection
Formulation Scope and Deliverables
Scope is defined case by case after consultation, because the appropriate formulation strategy depends on the enzyme, the intended application, and the storage and handling conditions the product must meet. The table below describes the parameter families that can be included and how each is typically scoped.
Deliverables are agreed in the statement of work and commonly include a lead formulation with supporting data, analytical results for activity and physical stability, and documentation of the conditions tested.
| Parameter | Typical Project Scope | Deliverable | Notes |
|---|---|---|---|
| Buffer and pH optimization | Condition space defined per project | Selected buffer and pH conditions with activity data | Basis for subsequent stabilizer screening |
| Stabilizer and excipient screening | Excipient panel scoped per project | Ranked stabilizer candidates with activity and stability readouts | Includes compatibility assessment |
| Lyophilization and drying support | Included when a solid form is selected | Dried formulation with post-reconstitution activity data | Cycle support scoped per project |
| Activity and stability assays | Assay panel scoped per project | Activity data under real-time and accelerated conditions | Condition set agreed in the SOW |
| Aggregation and fragmentation analysis | Method panel scoped per project | Physical stability data for candidate formulations | Complementary to activity readouts |
| Structural characterization | Method panel scoped per project | Structural assessment of formulated enzyme | Supports formulation selection |
| Compatibility and storage conditions | Contact materials and conditions scoped per project | Compatibility and storage condition data | Includes excipient and container contact |
| Delivery system development | Included when required by the application | Delivery format development with supporting data | Scoped per project |
Why Projects Choose This Service
Enzyme formulation sits between discovery and the application itself, and the decisions made there determine whether an enzyme remains useful outside the laboratory. Our service is structured to make those decisions with data and to keep the formulation aligned with how the product will actually be stored and used.
The differentiators below describe how the work is organized rather than fixed package options; scope is always defined against the specific enzyme and application.
Formulation Built Around the Use Case
The target product profile drives the formulation strategy, so that storage, handling, and use conditions are reflected in the conditions tested rather than assumed.
- Requirements defined from the intended application
- Storage and handling conditions built into testing
- Formulation choices tied to measured behavior
Activity and Physical Stability Together
Activity assays are combined with aggregation, fragmentation, and structural methods, giving a fuller picture of formulation performance than a single readout.
- Complementary analytical methods
- Detection of physical instability alongside activity loss
- Data set suitable for candidate comparison
Liquid and Solid Dosage Forms
Liquid, powder, granulate, and microgranulate formats can be evaluated, with lyophilization and drying support available when a solid form is preferred.
- Liquid and solid form evaluation
- Lyophilization and drying support
- Delivery system development when scoped
Project Setup and Support
Projects begin with a scoping discussion covering the enzyme, the intended application, and the conditions the product must meet. From there, the statement of work defines the formulation parameters, analytical methods, and deliverables.
Communication is structured around the project milestones, with a named scientific contact and review points as the work progresses.
| Item | Detail | Basis | Notes |
|---|---|---|---|
| Project initiation | Scoping discussion and statement of work | Defined per project | Covers enzyme, application, and target conditions |
| Technical support | A named scientific contact is assigned at project start, milestone review calls are scheduled, and email inquiries receive a response within 1 business day. | Standard for all projects | Applies across project types |
| Analytical methods | Activity, aggregation and fragmentation, structural characterization | Method panel scoped per project | Extended methods available when required |
| Reporting | Project report with formulation data and analytical results | Defined in the statement of work | Documentation of conditions tested |
Applications and Enzyme Types
Formulation optimization applies to enzymes used across therapeutic, diagnostic, and industrial settings, where the storage and use conditions differ but the underlying stability questions are similar.
Enzyme categories commonly encountered in formulation work include hydrolases, oxidoreductases, transferases, lyases, isomerases, and ligases, as well as custom or engineered enzymes developed for a specific application.
Therapeutic and Ex Vivo Use
Enzymes intended for therapeutic use or ex vivo processing must remain active under physiological or process conditions, making formulation a central part of development.
- Activity retention under use conditions
- Compatibility with process and delivery formats
- Stability data to support development decisions
Diagnostic and Bioanalysis Reagents
Diagnostic enzymes and assay reagents depend on consistent activity across storage and handling, and formulation work supports that consistency.
- Activity consistency across storage conditions
- Compatibility with reagent formats
- Stability testing aligned to use
Industrial and Process Enzymes
Industrial enzymes face demanding storage and process conditions, and formulation can extend the window in which activity is retained.
- Liquid and solid format options
- Stability under relevant conditions
- Support for scalable formats
Working With Us
Enzyme stability and formulation optimization is offered as part of a broader set of enzyme engineering and optimization services, alongside cell biology detection and biosafety evaluation capabilities. This combination supports projects that need to engineer, optimize, and functionally validate enzymes while addressing safety considerations for therapeutic or diagnostic use.
To begin, share the enzyme, the intended application, and the storage and handling conditions the product must meet. We will use that information to define a formulation scope and analytical plan for discussion.
FAQ
How do you decide which formulation parameters to test?
The starting point is the target product profile: the intended application, the enzyme's known liabilities, and the storage and handling conditions the product must survive. Those requirements determine which buffer, pH, stabilizer, and format options are evaluated, and the resulting scope is documented in the statement of work.
Can you support both liquid and solid enzyme formulations?
Yes. Liquid and solid formats can be evaluated, including powder, granulate, and microgranulate options. Where a dry form is preferred, lyophilization and drying support are included, and post-reconstitution activity is assessed as part of the analytical plan.
What analytical methods are used to assess stability?
Formulation performance is assessed with enzyme activity assays alongside physical stability methods such as aggregation and fragmentation analysis, and structural characterization covering primary, secondary, and tertiary structure. Compatibility testing with excipients and container materials and solubility assessment can be added depending on the project.
How is aggregation and fragmentation handled during development?
Aggregation and fragmentation are treated as physical instability endpoints and are monitored alongside activity, since physical changes can reduce the amount of functional enzyme even when chemical degradation is controlled. Candidate formulations are compared under the stress and storage conditions agreed for the project.
Can formulation work be combined with enzyme engineering?
Yes. Formulation optimization sits within a broader enzyme engineering and optimization offering, so projects that need to engineer an enzyme and then stabilize it can be coordinated. The combination is scoped against the specific enzyme and application rather than applied as a fixed sequence.
References
- Rautiola D, Updyke JL, Nelson KM, et al. Diazepam Prodrug Stabilizes Human Aminopeptidase B during Lyophilization. Molecular pharmaceutics. 2020;17(2):453-460. View on PubMed
- Manning MC, Holcomb RE, Payne RW, et al. Stability of Protein Pharmaceuticals: Recent Advances. Pharmaceutical research. 2024;41(7):1301-1367. View on PubMed
Discuss Your Enzyme Formulation Project
Share the enzyme, the intended application, and the storage and handling conditions the product must meet. We will use that information to define a formulation scope and analytical plan for discussion.